מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
levetiracetam, Quantity: 250 mg
Torrent Australasia Pty Ltd
Levetiracetam
Tablet, film coated
Excipient Ingredients: maize starch; sodium starch glycollate type A; silicon dioxide; povidone; purified talc; magnesium stearate; hypromellose; titanium dioxide; macrogol 400; indigo carmine
Oral
60 tablets
(S4) Prescription Only Medicine
Use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. Monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. Add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (JME). Add-on therapy in the treatment of Primary Generalized Tonic Clonic (PGTC) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (IGE).
Visual Identification: Blue colored, oval shaped, film coated tablets debossed with breakline seperating '250' and 'MG' on one side and '1014' on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2010-05-27